13F-HR filed by Yu Fan
Yu Fan filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 7 holding rows worth $53,237,962.
- Accession
- 0000950123-25-002400
- Filer
- CIK 1668029
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A combination report, 7 entries on the cover page, a total value of $53,237,962 stated on the cover page (in dollars after the unit check, H1), rows summing to $53,237,962 with VALUE read as dollars as filed, 13F file number 028-20833. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerABG Innovation Capital Partners III GP Limited 028-20837
- reports for this filerAlly Bridge Group (NY) LLC 028-20834
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CERIBELL INC | 15678C102 | COMMON STOCK | 1,222,202 | $31,630,588 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 912,000 | $13,151,040 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 789,618 | $6,206,397 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 163,456 | $1,284,764 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 22,503 | $599,705 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 57,190 | $257,355 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 69,303 | $108,113 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-25-002400 | this filing | 2025-02-14 | acceptance time not in the bulk data set |